J1720 Hydrocortisone Injection HCPCS Reimbursement

HCPCS Level II code J1720 denotes an injection of hydrocortisone sodium succinate, up to 100 mg, a short-acting corticosteroid frequently used for acute inflammation, allergic reactions, and as part of inpatient and outpatient treatment regimens. Nationally, this code matters because it captures a commonly administered parenteral medication across multiple care settings, affecting outpatient drug billing, inventory management, and payer coverage determinations. Key payers addressed in this summary include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will learn what J1720 represents clinically and operationally, which payers commonly cover the service, and what typical sites of service and service types are associated with the code. The publication also provides benchmarks and policy-relevant context on billing practice, claims processing, and reimbursement considerations for hydrocortisone injections. Where specific data are missing from the input, the text notes that information is not available. The content is intended for a national audience of billing professionals, practice managers, and policy analysts seeking concise, actionable context about the HCPCS Level II code J1720.

Billing Code Overview

HCPCS Level II code J1720 represents an injection of hydrocortisone sodium succinate, up to 100 mg. This service is typically administered as an intravenous or intramuscular corticosteroid injection used for anti-inflammatory and immunosuppressive effects.

Service type: Medication injection
Typical site of service: Physician office, outpatient clinic, emergency department, or hospital outpatient setting

Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.

Clinical Context

A typical patient is an adult presenting to an emergency department, urgent care clinic, or outpatient infusion center with acute exacerbation of an inflammatory condition such as severe allergic reaction, adrenal insufficiency, or acute asthma/COPD flare. A clinician evaluates the patient, documents history and exam, and determines that parenteral corticosteroid therapy is indicated. The provider orders J1720 (hydrocortisone sodium succinate injection, up to 100 mg). Nursing prepares and administers the medication via intravenous push, IV infusion, or intramuscular injection per facility protocol, documents lot number, dose, route, and time; monitors vital signs and response; and records any adverse reaction. If provided during a surgical encounter, modifier reporting for anesthesia, facility, or professional relationships may be appended. Billing includes the drug HCPCS J1720, the appropriate visit or procedure CPT code for evaluation or treatment (separately reported), and any applicable modifiers to indicate distinct circumstances such as services by multiple surgeons, discontinued services, or drug wastage per payer rules.

Coding Specifications

Modifier	Description	When to Use
`JW`	Drug discarded/not administered to any patient	Report when part of the single-use vial is discarded per payer rules for drug waste reimbursement

Taxonomy Code	Specialty	Notes
`207RG0300X`	Emergency Medicine Physician	Commonly orders and oversees IV corticosteroid administration in ED settings
`208D00000X`	General Practice / Family Medicine	Manages outpatient exacerbations and may administer IM/IV hydrocortisone in clinics
`207P00000X`	Internal Medicine Physician	Treats acute medical flares and prescribes/administers parenteral steroids
`364S00000X`	Registered Nurse	Performs medication preparation and administration and documents administration details
`363A00000X`	Physician Assistant	Evaluates patients and orders/administers injectable corticosteroids under supervision

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`E27.1`	Primary adrenocortical insufficiency (Addison disease)	Hydrocortisone is replacement therapy for adrenal insufficiency crises and maintenance in acute decompensation
`T78.2XXA`	Anaphylactic shock, unspecified, initial encounter	Parenteral hydrocortisone is used as adjunctive therapy in severe allergic reactions
`J45.909`	Unspecified asthma, uncomplicated	Acute asthma exacerbations may require systemic corticosteroids such as hydrocortisone
`J44.1`	Chronic obstructive pulmonary disease with (acute) exacerbation	Systemic steroids are commonly used to treat COPD exacerbations
`L50.9`	Urticaria, unspecified	Severe urticaria or angioedema may be treated with parenteral corticosteroids

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Often used when hydrocortisone is administered as an intramuscular injection in outpatient/clinic settings
`96365`	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	Used when hydrocortisone is given as an IV infusion and infusion monitoring is required
`96374`	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance/drug	Used when hydrocortisone is administered as an IV push in clinic or hospital settings
`99283`	Emergency department visit for the evaluation and management of a patient, moderate severity	Common ED E/M code reported when evaluation and IV hydrocortisone administration are performed
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Used when hydrocortisone is administered during a brief outpatient visit

OpenPayer

Summary & Overview

HCPCS J1720: Hydrocortisone Sodium Succinate Injection, up to 100 mg